John R Fullarton

6PUBLICATIONS
17CO-AUTHORS
Epidemiological modellingEnvironmental epidemiologyPharmaceutical delivery technologiesInfant and child healthImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 16, 2025
Post-Pandemic Dynamics of the Global Circulation of Human Metapneumovirus and Respiratory Syncytial Virus.

Marie-Noëlle Billard, Joanne G Wildenbeest, Ruben Kole

|Feb 28, 2025
Cost-effectiveness of wastewater and environmental monitoring of respiratory syncytial virus to guide universal infant immunoprophylaxis in Canada.

Élisabeth Mercier, John R Fullarton, Bosco A Paes

|Jul 27, 2023
Efficacy of oral prolonged-release mesalazine in moderately active ulcerative colitis.

Kristine Paridaens, John R Fullarton, Simon P L Travis

|Apr 17, 2023
Impact of using the International Risk Scoring Tool on the cost-utility of palivizumab for preventing severe respiratory syncytial virus infection in Canadian moderate-to-late preterm infants.

Barry S Rodgers-Gray, John R Fullarton, Xavier Carbonell-Estrany

|Dec 21, 2021
Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis.

Axel U Dignass, Kristine Paridaens, Sameer Al Awadhi

|Aug 18, 2021
Efficacy and safety of oral Pentasa (prolonged-release mesalazine) in mild-to-moderate ulcerative colitis: a systematic review and meta-analysis.

Kristine Paridaens, John R Fullarton, Simon P L Travis

Pageof 1

Frequent Collaborators

3 joint publications

Barry S Rodgers-Gray

3 joint publications

Kristine Paridaens

3 joint publications

Simon P L Travis

2 joint publications

Bosco A Paes